Realtime | Geld | Brief | Zeit |
---|---|---|---|
0,938 | 0,966 | 10.05. |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
30.04. | ORIOLA OYJ: The Swedish Competition Authority prohibits Oriola's sale of Svensk dos AB to Apotekstjänst Sverige AB | 2 | Cision News | ||
25.04. | Oriola Corporation: Oriola Corporation's Interim Report January-March 2024 | 98 | GlobeNewswire (Europe) | Oriola Corporation Stock Exchange Release 25 April 2024 at 8.30 a.m. EEST
Oriola Corporation's Interim Report January-March 2024
Sales growth and improved profitability
January-March 2024 highlights
Invoicing... ► Artikel lesen | |
27.03. | Oriola Partners With HCLTech to Enhance Customer Experience Through Digital Transformation | 254 | Business Wire | HCLTech, a global technology company, announced that it has been selected by Oriola Corporation, a leading health and wellbeing company operating in the Nordic region, to accelerate Oriola's digital... ► Artikel lesen | |
19.03. | ORIOLA OYJ: Resolutions of the Annual General Meeting of Oriola Corporation and the decisions of the constitutive meeting of the Board of Directors | 2 | Cision News | ||
15.03. | ORIOLA OYJ: Oriola Corporation's disposal of own shares based on the share-based incentive plan | 1 | Cision News | ||
27.02. | ORIOLA OYJ: Oriola Corporation's Annual Report 2023 published | 2 | Cision News | ||
16.02. | ORIOLA OYJ: Notice to Oriola Corporation's Annual General Meeting 2024 | 1 | Cision News | ||
16.02. | Oriola Corporation: Oriola Corporation's Financial Statements Release 1 January-31 December 2023 | 19 | GlobeNewswire (Europe) | Oriola Corporation Stock Exchange Release 16 February 2023 at 8.30 a.m. EET
Oriola Corporation's Financial Statements Release 1 January-31 December 2023
Strong growth in profitability excluding Swedish... ► Artikel lesen | |
02.02. | ORIOLA OYJ: Oriola Corporation to publish its Financial Statements Release 2023 on 16 February 2024 | 1 | Cision News | ||
24.01. | ORIOLA OYJ: Proposals of the Shareholders' Nomination Board of Oriola Corporation concerning the Board of Directors to be elected by the 2024 Annual General Meeting | 1 | Cision News | ||
12.01. | ERP-Umstieg bei Oriola: Oriola AB, ein in den nordischen Ländern und Osteuropa aktiver Pharmagroßhändler ... | 4 | IT-ZOOM | ||
10.01. | ORIOLA OYJ: Oriola to invest in ERP and warehouse management as part of the recently launched strategy to enhance efficiency and operational excellence | 2 | Cision News |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
CARDINAL HEALTH | 92,76 | +0,37 % | Cardinal Health-Aktie büßt 4,11 Prozent ein (91,6967 €) | Im Minus liegt zur Stunde das Wertpapier von Cardinal Health . Die Aktie notiert gegenwärtig bei 98,75 US-Dollar. Ein Kursverlust in Höhe von 4,23 US-Dollar müssen derzeit die Aktionäre von Cardinal... ► Artikel lesen | |
RESMED | 199,05 | +0,28 % | Dividendenbekanntmachungen (08.05.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADDNODE GROUP AB SE0017885767 1 SEK 0,0856 EUR ALANTRA PARTNERS SA ES0126501131 - 0,08 EUR ALZCHEM GROUP AG DE000A2YNT30 - 1,2 EUR ARISE... ► Artikel lesen | |
ZIMMER BIOMET | 112,45 | +0,45 % | Analyst Expectations For Zimmer Biomet Holdings' Future | ||
CO-DIAGNOSTICS | 1,030 | 0,00 % | Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results | SALT LAKE CITY, May 9, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX) ("Co-Dx," or the "Company"), a molecular diagnostics company with a unique, patented platform for the development... ► Artikel lesen | |
CLARIANE | 3,578 | +0,85 % | CLARIANE: Implementation of the Plan to Strengthen Clariane's Financial Structure - Disposal of the Hospitalisation à Domicile (HAD) Activity in France | Regulatory News:
Clariane (Paris:CLARI) (CLARIA.PA ISIN FR0010386334): the Group announces today that it has received a put option agreement from the Fondation Santé Service and has granted an... ► Artikel lesen | |
IZOTROPIC | 0,094 | +48,57 % | EQS-News: Izotropic Corporation: Izotropic erhält Antwort von der US-Behörde FDA | EQS-News: Izotropic Corporation
/ Schlagwort(e): Miscellaneous
Izotropic erhält Antwort von der US-Behörde FDA
31.01.2024 / 18:58 CET/CEST
Für den Inhalt der Mitteilung... ► Artikel lesen | |
INSPIREMD | 2,040 | +4,62 % | InspireMD, Inc.: InspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update | - Record fourth quarter 2023 CGuard EPS revenue of $1.76 million increased 71.6% over fourth quarter 2022 - - Announced positive 30-day data from the Company's ongoing U.S. Investigational Device... ► Artikel lesen | |
ASTRANA HEALTH | 33,400 | -7,73 % | Astrana Health, Inc. Reports First Quarter 2024 Results | Company to Host Conference Call on Tuesday, May 7, 2024, at 2:30 p.m. PT / 5:30 p.m. ET
ALHAMBRA, Calif., May 7, 2024 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries... ► Artikel lesen | |
RESHAPE LIFESCIENCES | 0,168 | -1,35 % | ReShape Lifesciences files to sell 11.7M common shares for holders | ||
UNIDOC HEALTH | 0,406 | -2,87 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 02.04.2024 | Das Instrument 7ZO SE0017486426 TENDO AB EQUITY wird cum Kapitalmassnahme gehandelt am 02.04.2024 und ex Kapitalmassnahme am 03.04.2024 The instrument 7ZO SE0017486426 TENDO AB EQUITY is traded cum... ► Artikel lesen | |
PANGENOMIC HEALTH | 0,088 | +19,05 % | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 21.03.2024 | The following instruments on XETRA do have their first trading 21.03.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 21.03.2024
Aktien
1 CA02115L2003 Alset Capital Inc.
2... ► Artikel lesen | |
ORGANOGENESIS | 2,800 | +33,33 % | Organogenesis Holdings Inc. (ORGO) Q1 2024 Earnings Call Transcript | ||
CATHETER PRECISION | 0,523 | +1,95 % | Catheter Precision, Inc. Announces Receipt of New Purchase Order and Product Evaluation at New Hospital | see attached FORT MILL, SC / ACCESSWIRE / May 7, 2024 / Catheter Precision, Inc. (the "Company") (NYSE American:VTAK), a US based innovative medical device company focused on electrophysiology products... ► Artikel lesen | |
CROSSJECT | 1,982 | -2,12 % | Crossject reports audited financial results for 2023 | Dijon, France April 25, 2024 -- Crossject (ISIN: FR0011716265; Euronext: ALCJ), a specialty pharmaceuticals company developing products for emergency situations harnessing its proprietary needle-free... ► Artikel lesen | |
BAUSCH+LOMB | 14,100 | +2,17 % | Morgan Stanley upgrades Bausch + Lomb, cites improving margins |